AFFiRiS AG logo

AFFiRiS AG

Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you.

2 employees · est. 2003 · Wien, Austria

VS
Cognition Therapeutics, Inc. logo

Cognition Therapeutics, Inc.

Advancing Accessible Solutions for Complex Neurodegenerative Diseases

29 employees · est. 2007 · United States

AFFiRiS AG is the older company (2003 vs 2007); Cognition Therapeutics, Inc. is the larger of the two.

Side-by-Side Comparison

AFFiRiS AG Cognition Therapeutics, Inc.
Founded
2003 older 2007
Headquarters
Wien, Austria United States
Employees
2 29 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Unknown IPO
Total Funding
$47.00M $161.89M
Funding Rounds
4 24
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Immunotherapy, Neurodegenerative Diseases, Parkinson's Disease, Alzheimer's Disease, Multiple System Atrophy, Dementia With Lewy Bodies, Huntington's Disease, Clinical-stage Biotechnology, SAIT, AFFITOME Technology, Peptide Vaccines, Vienna, Austria, Clinical Trials, Monoclonal Antibody Neuroscience, Clinical Stage, Drug Development, Small Molecule Therapeutics, Neurodegenerative Diseases, Alzheimer's Disease, Toxic Proteins, Cognitive Decline, Biological Expertise, Assays, Medicinal Chemistry, Innovative Therapeutics, Neuro-ophthalmic Disorders, Age-related Degenerative Diseases, Cellular Damage Responses
Website
affiris.com cogrx.com
AFFiRiS AG logo

About AFFiRiS AG

AFFiRiS AG is a clinical-stage biotechnology company based in Austria, founded in 2003. The company's slogan, "Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you," encapsulates their mission to challenge established treatment options for neurode...

Cognition Therapeutics, Inc. logo

About Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc. is a biotechnology and health care company founded in 2007 and based in the United States. The company's slogan "Targeting age-related degenerative diseases" reflects its primary focus. Cognition Therapeutics, Inc. is currently in the clinical stage and is dedicated to d...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at AFFiRiS AG and Cognition Therapeutics, Inc. — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at AFFiRiS AG and Cognition Therapeutics... — by email.

Frequently Asked Questions

AFFiRiS AG — Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you.. Cognition Therapeutics, Inc. — Advancing Accessible Solutions for Complex Neurodegenerative Diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AFFiRiS AG has raised $47.00M while Cognition Therapeutics, Inc. has raised $161.89M.
AFFiRiS AG and Cognition Therapeutics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AFFiRiS AG with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy